Entity
  • SEQENS

    Created in 2003


  • Up & running (A)
    Existing signals show a regular activity
  • Social networks

    381 573 42,711
  • Entity types

  • Location

    21 Chem. de la Sauvegarde, 69130 Écully, France

    Écully

    France

  • Employees

    Scale: 1001-5000

    Estimated: 1,305

  • SIREN

    444465736
  • Engaged catalyst

    39
    0 0
  • Added in Motherbase

    4 years, 1 month ago
Description
  • Value proposition

    Our science for your future

    SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients.

    The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.

    SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.


    Pharmaceutical Synthesis, Specialty Ingredients, Cosmetics, Custom Specialties, R&D, CDMO, CRDO, Generics, Innovative Pharmaceuticals, and Personnal Care

  • Original language

    Our science for your future

    Seqens est un leader mondial de la synthèse pharmaceutique et des ingrédients de spécialité.

    Le groupe génère un chiffre d'affaires de 1.1 milliard d'€ et exploite 16 sites de production ainsi que 9 centres de R&D en Europe, en Amérique du Nord et en Asie. 3 300 collaborateurs contribuent au succès de Seqens, parmi lesquels plus de 350 scientifiques, ingénieurs et experts qui développent des solutions sur mesure pour nos clients.

    Seqens est un acteur intégré qui offre un large portefeuille de principes actifs, d'intermédiaires pharmaceutiques et d'ingrédients de spécialité. Nous développons et industrialisons les molécules les plus exigeantes, en prenant appui sur notre capacité à innover, à développer et à mettre en œuvre les meilleures technologies disponibles.

  • Pharmaceutical Solutions, Personal Care & Specialty Ingredients - SEQENS

    SEQENS is an integrated global leader in Health, Personal Care and Specialty Ingredients with 16 production sites and 9 R&D centres across the world,

  • https://www.seqens.com/
Catalyst interactions
Catalyst TypeTweets Articles
Artelia
Artelia
Construction, Environment, IT Services and IT Consulting
Artelia
Construction, Environment, IT Services and IT Consulting
Other

13 Aug 2024


Le Figaro
Le Figaro
Media, Newspaper Publishing
Le Figaro
Media, Newspaper Publishing
Other

28 Nov 2023


Ministry of Economy
Ministry of Economy
Government Administration
Ministry of Economy
Government Administration
Other

24 Jun 2023


CNRS
CNRS
Research, Research Services
CNRS
Research, Research Services
Other

28 Jun 2024


Groupe VYV
Groupe VYV
Insurance
Groupe VYV
Insurance
Other

16 Oct 2019


BFM Business
BFM Business
Media, Broadcast Media Production and Distribution
BFM Business
Media, Broadcast Media Production and Distribution
Other

7 Mar 2023


MEDEF
MEDEF
NGO, Think Tank, Civic and Social Organizations
MEDEF
NGO, Think Tank, Civic and Social Organizations
Other

5 Dec 2024


La Tribune
La Tribune
Media, Newspapers
La Tribune
Media, Newspapers
Other

16 Oct 2023


Lyonbiopôle Auvergne-Rhône-Alpes
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Lyonbiopôle Auvergne-Rhône-Alpes
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

20 Mar 2024


Cosmetic Valley
Cosmetic Valley
Cosmetics, Public business cluster, French Cluster, Personal Care Product Manufacturing
Cosmetic Valley
Cosmetics, Public business cluster, French Cluster, Personal Care Product Manufacturing
Other

26 Jul 2022


Social network dynamics
Loading...